4 Stocks That Will Benefit From Biogen’s Alzheimer’s Drug

Is your money at stake??

Published: June 18, 2021 Forget Buy-and-Hold Strategies I'm getting ready to reveal how I spot trades with the chance to return upward of five times my initial investment — every single month.  Not only does this strategy protect traders' portfolios from long-term volatility, but it gives them the chance to bank massive winners in just 24 hours.  Traders have never seen anything quite like this before.  With my Weekly Blitz Alerts, people can throw their old buy-and-hold strategy out the window. And forget spending hours reading through pages of earnings reports and squinting at stock charts.  To start collecting these 24-hour home runs, all one needs to do is follow my trading instructions the minute I issue a Blitz Alert. It's that simple. Click to See the Trading Strategy Lance Ippolito Lance is a professional trader and a successful entrepreneur with over 10 years of experience in the financial markets. 4 Stocks That Will Benefit From Biogen's Alzheimer's Drug If you missed it this past week, there was big news in biotech land as the FDA announced its approval of Biogen's new Alzheimer's drug.  This is a game-changer that will hopefully lead to big things in the fight against Alzheimer's, which reportedly affects more than 6 million people in the U.S. By 2050, this number is expected to top 13 million.  If you didn't own Biogen — or even if you did — before the big announcement that sent shares rocketing 40% higher, I'd like to discuss stocks that will benefit from its Alzheimer's drug… Because they have drugs of their own awaiting FDA approval. If and when they get it… These Tickers Could Explode Like Biogen What's Next for Pot Stocks?: 4 Charts Traders Must See Right Now June 15, 2021 The misfit band of Reddit retail traders is turning their sights to cannabis stocks like Tilray, but they must not be looking at the same charts I am… Continue Reading Is the DraftKings Short Report and Ensuing Sell-Off a Bullish Sign? June 16, 2021 Another high-profile short report crashed into the market this week, making loads of headlines and — more importantly — lucrative trading opportunities.... Continue Reading A New Money Crew Publication Disclaimer: The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein.  Any performance results discussed herein represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment.  Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions. This email was sent to phanphuongthanh89.822152@blogger.com by WealthPress LLC 495 Town Plaza Ave | | Jacksonville | FL | 32081 Forward to a friend | Unsubscribe From All WealthPress Emails